Aspirin
Tracked across 3 events · 22 articles · First seen Jan 29, 2026 · Last active Mar 04, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
NewsDesk Dashboard
Tech
The ASPREE study found that low-dose Aspirin did not reduce cancer incidence among older adults and significantly increased the risk for cancer mortality. This suggests that the protective benefits of Aspirin seen in younger populations do not translate to adults older than 70 years.
Jan 29, 2026 · 7 articles
Tech
A new Cochrane review suggests that Aspirin does not reliably prevent bowel cancer in the general population and carries immediate risks of serious bleeding. This challenges previous assumptions about its widespread use for cancer prevention.
Feb 26, 2026 · 7 articles
Tech
Aspirin is another antiplatelet drug being investigated in the Aspiring clinical trial to assess its role in reducing the risk of subsequent strokes and heart attacks after a haemorrhagic stroke.
Feb 13, 2026 · 8 articles
NEWSDESK
Track Aspirin live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard